Market Research Report
Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025
|Published by||Orion Market Research Pvt Ltd||Product code||947756|
Delivery time: 2-3 business days
|Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025|
|Published: March 27, 2020||Content info:||
Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Asia-Pacific digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 9.1% during the forecast period. Asia-Pacific market has been witnessing considerable growth owing to the rise in the incidence of infectious diseases and genetic disorders such as cancer, HIV and hepatitis. Due to the prevalence of various chronic diseases such as CVD and cancer in the region the demand for dPCR and qPCR instruments is increasing at consistent basis.
Additionally, increasing advancement in PCR technique and increasing research activities that use the PCR supplement the growth of the market. However, technical shortcomings in the dPCR and qPCR along with the high price of advanced PCR devices are hampering the growth of the market during the forecast period. Thus, the market for dPCR and qPCR is rapidly growing in the region as the dPCR and qPCR are used in the diagnosis of the infectious diseases. Additionally, adoption in these Asian countries will reduce the economic burden of cancer on the respective governments by the timely and efficient diagnosis of diseases.
The market growth in the region is attributed by the presence of some crucial players, such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Takara Bio Inc. and many others. These key companies are actively adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment. For instance, in January 2020, Takara Bio Inc. launched a new facility for research and manufacturing of regenerative medicine as the Center for Gene and Cell Processing II in Kusatsu, Shiga. Owing to an increasingly global presence, the company was facing insufficient capacity for manufacturing which led to this expansion.
The market study of the Asia-Pacific dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include::
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
The Report covers: